Homepage
Medication Guide
What Are the Indications of Elacestrant (Orserdu)?
Elacestrant (Orserdu) is a novel estrogen receptor antagonist. It was approved for marketing by the U.S. FDA in 2023, providing a precise treatment option for patients with advanced breast cancer harb...
504
Monday, December 1st, 2025, 11:09
What Are the Purchase Channels for Elacestrant (Orserdu)?
Elacestrant (Orserdu) is a novel estrogen receptor antagonist that plays an important role in the treatment of ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.What Are th...
504
Monday, December 1st, 2025, 10:45
Side Effects of Binimetinib (Mektovi)
Binimetinib (Mektovi) is a selective mitogen-activated protein kinase (MEK) inhibitor. It primarily blocks the RAS/RAF/MEK/ERK signaling pathway by inhibiting the activity of MEK1 and MEK2, thereby su...
506
Monday, December 1st, 2025, 10:42
What Are the Precautions for Binimetinib (Mektovi) Use?
Binimetinib (Mektovi) is a MEK inhibitor, usually used in combination with encorafenib, for the treatment of unresectable or metastatic melanoma positive for BRAF V600E or V600K mutations, as well as ...
504
Monday, December 1st, 2025, 10:38
Dosage and Administration, Recommended Dose of Binimetinib (Mektovi)
Binimetinib (Mektovi) is a kinase inhibitor, usually used in combination with encorafenib, for the treatment of unresectable or metastatic melanoma positive for BRAF V600E or V600K mutations, as well ...
502
Monday, December 1st, 2025, 10:10
What Are the Purchase Channels for Binimetinib (Mektovi)?
Binimetinib (Mektovi) is an important MEK inhibitor that plays a key role in the treatment of melanoma and lung cancer. As this medication is a prescription drug and related to significant health and ...
506
Monday, December 1st, 2025, 09:55
What are the Indications of Binimetinib (Mektovi)?
Binimetinib (Mektovi) is a highly potent and selective mitogen-activated protein kinase (MEK) inhibitor that plays a crucial role in the field of cancer treatment. As a molecular targeted therapy drug...
502
Monday, December 1st, 2025, 09:44
Side Effects of Lomitapide (Juxtapid)
Lomitapide (Juxtapid) is a microsomal triglyceride transfer protein (MTP) inhibitor, primarily indicated for the treatment of homozygous familial hypercholesterolemia (HoFH). Although this medication ...
508
Monday, December 1st, 2025, 09:28
What are the Precautions for Lomitapide (Juxtapid) Use?
Lomitapide (Juxtapid) is a novel microsomal triglyceride transfer protein inhibitor, indicated as an adjunctive therapy for homozygous familial hypercholesterolemia. Its unique mechanism of action and...
504
Monday, December 1st, 2025, 09:19
Dosage and Administration, Recommended Dosage of Juxtapid (Lomitapide)
Juxtapid (lomitapide) is a microsomal triglyceride transfer protein inhibitor specifically indicated for the treatment of homozygous familial hypercholesterolemia (HoFH). As a potent lipid-lowering dr...
506
Friday, November 28th, 2025, 11:07
33 / 200
1994 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved